Selective targeting of the AKT1 (E17K) mutation: advances in precision oncology and therapeutic design
Crossref DOI link: https://doi.org/10.1007/s12672-025-03083-0
Published Online: 2025-07-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Xiaoyan
Zhang, Danfeng
Xue, Jiapeng
Li, Zhi
Text and Data Mining valid from 2025-07-03
Version of Record valid from 2025-07-03
Article History
Received: 18 March 2025
Accepted: 25 June 2025
First Online: 3 July 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.